Overview

A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women

Status:
Completed

Trial end date:
2017-07-10

Target enrollment:

Participant gender:

Summary

The purpose of this research is to determine the effects of Metformin, a well tolerated drug widely prescribed for treatment of Type 2 Diabetes Mellitus, on endometrium cancer patients.

Phase:

Phase 2

Details

Lead Sponsor:

University of Arkansas

Treatments:

Metformin